• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Neutrons produce first direct 3D maps of water during cell membrane fusion

Bioengineer by Bioengineer
September 20, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: ORNL/Jill Hemman

New 3D maps of water distribution during cellular membrane fusion are accelerating scientific understanding of cell development, which could lead to new treatments for diseases associated with cell fusion. Using neutron diffraction at the Department of Energy's Oak Ridge National Laboratory, researchers have made the first direct observations of water in lipid bilayers used to model cell membrane fusion.

The research, published in Journal of Physical Chemistry Letters, could provide new insights into diseases in which normal cell fusion is disrupted, such as Albers-Schönberg disease (osteopetrosis), help facilitate the development of fusion-based cell therapies for degenerative diseases, and lead to treatments that prevent cell-to-cell fusion between cancer cells and non-cancer cells.

When two cells combine during fertilization, or a membrane-bound vesicle fuses during viral entry, neuron signaling, placental development and many other physiological functions, the semi-permeable membrane bilayers between the fusing partners must be merged to exchange their internal contents. As the two membranes approach each other, hydration forces increase exponentially, which requires a significant amount of energy for the membranes to overcome. Mapping the distribution of water molecules is key to understanding the fusion process.

Researchers used the small-angle neutron scattering (EQ-SANS) instrument at ORNL's Spallation Neutron Source and the biological small-angle neutron scattering (Bio-SANS) instrument at the High Flux Isotope Reactor, both of which can probe structures as small as a few nanometers in size.

"We used neutrons to probe our samples, because water typically can't be seen by x-rays, and because other imaging techniques can't accurately capture the extremely rapid and dynamic process of cellular fusion," said Durgesh K. Rai, co-author and now a post-doctoral associate at the Cornell High Energy Synchrotron Source at Cornell University. "Additionally, the cold, lower-energy neutrons at EQ-SANS and Bio-SANS won't cause radiation damage or introduce radicals that can interfere with lipid chemistry, as x-rays can do."

The researchers' water density map indicates the water dissociates from the lipid surfaces in the initial lamellar, or layered, phase. In the intermediate fusion phase, known as hemifusion, the water is significantly reduced and squeezed into pockets around a stalk–a highly curved lipid "bridge" connecting two membranes before fusion fully occurs.

"For the neutron scattering experiments, we replaced some of the water's hydrogen atoms with deuterium atoms, which helped the neutrons observe the water molecules during membrane fusion," said Shuo Qian, the study's corresponding author and a neutron scattering scientist at ORNL. "The information we obtained could help in future studies of membrane-acting drugs, membrane-associated proteins, and peptides in a membrane complex."

###

The research was supported by the DOE Office of Science and ORNL Laboratory Directed Research and Development program.

The Spallation Neutron Source and High Flux Isotope Reactor are DOE Office of Science User Facilities. UT-Battelle manages ORNL for the DOE's Office of Science. The Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, please visit http://science.energy.gov/.

Media Contact

Paul Boisvert
[email protected]
502-229-4466
@ORNL

http://www.ornl.gov

Related Journal Article

http://dx.doi.org/10.1021/acs.jpclett.8b01602

Share17Tweet8Share2ShareShareShare2

Related Posts

Ginsenoside Rg1 Enhances Intervertebral Disc Repair Mechanism

November 6, 2025

Repurposed Drug Combo Shows Promise Against Ovarian Cancer

November 6, 2025

Impact of Age on Elite Chinese Junior Basketball Players

November 6, 2025

Hospitalist Consults Improve Outcomes for Opioid Patients

November 6, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1301 shares
    Share 520 Tweet 325
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    313 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    206 shares
    Share 82 Tweet 52
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    138 shares
    Share 55 Tweet 35

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Mitochondrial Genomes Reveal Invasive Scale Insect Evolution

Ginsenoside Rg1 Enhances Intervertebral Disc Repair Mechanism

Repurposed Drug Combo Shows Promise Against Ovarian Cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.